Comparison of Bier Block and Lidocaine-Propofol Mixture for Prevention of Propofol Injection Pain

by palligoelme@gmail.com | Dec 16, 2025 | Clinical Trials

​ Conditions: Propofol Injection Pain Interventions: Drug: propofol; Drug: Lidocaine – Propofol Mixture; Drug: Lidocaine – Bier Block Sponsors: Asma Ladib Completed Conditions: Propofol Injection Pain Interventions: Drug: propofol; Drug: Lidocaine –...

Accelerating Motor Recovery in Glioma Patients Using Postoperative nrTMS

by palligoelme@gmail.com | Dec 16, 2025 | Clinical Trials

​ Conditions: Glioma Interventions: Device: transcranial magnetic stimulation (TMS); Device: sham stimulation Sponsors: Beijing Neurosurgical Institute Active, not recruiting Conditions: Glioma Interventions: Device: transcranial magnetic stimulation (TMS); Device:...

Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma

by palligoelme@gmail.com | Dec 16, 2025 | Clinical Trials

​ Conditions: Phase 2; Zanzalintinib; Pembrolizumab; Advanced/Metastatic; Soft-Tissue Sarcoma Interventions: Drug: Zanzalintinib; Drug: Pembrolizumab Sponsors: M.D. Anderson Cancer Center; Exelixis Not yet recruiting Conditions: Phase 2; Zanzalintinib; Pembrolizumab;...

Atelocollagen ＆ Hyaluronic Acid Correlation With Enhancement of Rotator Cuff Healing: Synergistic Effect?

by palligoelme@gmail.com | Dec 16, 2025 | Clinical Trials

​ Conditions: Rotator Cuff Tear Interventions: Procedure: Atelo collagen injection; Procedure: Hyaluronic acid injection Sponsors: Hallym University Dongtan Sacred Heart Hospital; Ministry of Science and ICT, Republic of Korea Active, not recruiting Conditions:...

Pharmacokinetics of Olverembatinib in Participants With Hepatic Impairment

by palligoelme@gmail.com | Dec 15, 2025 | Clinical Trials

​ Conditions: Pharmacokinetic; Olverembatinib Interventions: Drug: Olverembatinib 20mg Sponsors: Ascentage Pharma Group Inc.; Guangzhou Healthquest Pharma Co., Ltd Not yet recruiting Conditions: Pharmacokinetic; Olverembatinib Interventions: Drug: Olverembatinib 20mg...

Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer

by palligoelme@gmail.com | Dec 15, 2025 | Clinical Trials

​ Conditions: Colorectal Cancer Interventions: Drug: Oxaliplatin; Drug: Capecitabine; Drug: Cemiplimab; Drug: Fianlimab; Drug: REGN7075 Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Regeneron Pharmaceuticals Not yet recruiting Conditions:...